
Melanoma vaccine success sparks hope for broader cancer treatment
A personalized cancer vaccine developed by Merck and Moderna has shown success in preventing the return of melanoma in a large clinical trial, raising hopes that the same approach could eventually be used against many other types of cancer.


















